Gibson Dunn has advised Avere Therapeutics. Cooley has advised the placement agents. Avere Therapeutics, Inc. (“Avere”), a privately-held biotechnology company, has announced a $500 million private...
Avere Therapeutics Secures $500 Million in Private Placement for Development of Once-Weekly Oral IL-23 Therapy
Synlogic and Caldera Therapeutics Announce Merger and $278 Million Private Placement
Mintz has advised Synlogic Inc. Fenwick & West has advised Caldera Therapeutics. Cooley has advised the placement agents to Caldera Therapeutics. Synlogic, Inc. (OTC: SYBX) and...
Remix Therapeutics and Passage Bio Announce Merger and $100 Million Private Placement
Latham & Watkins LLP has advised Remix Therapeutics. Fenwick & West LLP has advised Passage Bio. Cooley LLP has advised Goldman Sachs & Co. LLC, Jefferies...